Post by Mr. Clean on Mar 8, 2009 11:06:58 GMT -5
Verenium owns a robust intellectual property portfolio with patents covering our key technologies in the discovery, optimization, production and use of novel protein-based products. In addition, we maintain numerous composition of matter patents covering our novel enzyme products and product candidates. Verenium currently has over 300 issued patents and over 400 patents pending (as of June 2008).
Selected Patents
5,939,250 Production of enzymes having desired activities by mutagenesis. 5,958,672 Protein activity screening of clones having DNA from uncultivated microorganisms 6,001,574 Production and use of normalized DNA libraries 6,168,919 Screening methods for enzymes and enzyme kits 6,171,820 Saturation mutagenesis in directed evolution 6,280,926 Gene expression library produced from DNA from uncultivated microorganisms and methods for making the same 6,344,328 Method for screening for enzyme activity 6,455,254 Sequence based screening 6,537,776 Synthetic ligation reassembly in directed evolution 6,632,600 Altered thermostability of enzymes
Selected Patents
5,939,250 Production of enzymes having desired activities by mutagenesis. 5,958,672 Protein activity screening of clones having DNA from uncultivated microorganisms 6,001,574 Production and use of normalized DNA libraries 6,168,919 Screening methods for enzymes and enzyme kits 6,171,820 Saturation mutagenesis in directed evolution 6,280,926 Gene expression library produced from DNA from uncultivated microorganisms and methods for making the same 6,344,328 Method for screening for enzyme activity 6,455,254 Sequence based screening 6,537,776 Synthetic ligation reassembly in directed evolution 6,632,600 Altered thermostability of enzymes